2001
Access to medical care and service utilization among injection drug users with HIV/AIDS
Knowlton A, Hoover D, Chung S, Celentano D, Vlahov D, Latkin C. Access to medical care and service utilization among injection drug users with HIV/AIDS. Drug And Alcohol Dependence 2001, 64: 55-62. PMID: 11470341, DOI: 10.1016/s0376-8716(00)00228-3.Peer-Reviewed Original ResearchConceptsCase managementService utilizationDrug treatmentCurrent drug injectorsOutpatient service usePhysical functioning limitationsEmergency room useInjection drug usersCurrent drug useDaily alcohol useHIV/AIDSSubstance abuse treatmentHIV careAIDS diagnosisOutpatient careFunctioning limitationsDrug injectorsOutpatient servicesService useDrug usersDrug useMedical careAbuse treatmentHospital servicesAlcohol useBlood-Borne and Sexual Transmission of Human Herpesvirus 8 in Women with or at Risk for Human Immunodeficiency Virus Infection
Cannon M, Dollard S, Smith D, Klein R, Schuman P, Rich J, Vlahov D, Pellett P. Blood-Borne and Sexual Transmission of Human Herpesvirus 8 in Women with or at Risk for Human Immunodeficiency Virus Infection. New England Journal Of Medicine 2001, 344: 637-643. PMID: 11228278, DOI: 10.1056/nejm200103013440904.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnalysis of VarianceBlood-Borne PathogensFemaleHepatitis, Viral, HumanHerpesviridae InfectionsHerpesvirus 8, HumanHeterosexualityHIV InfectionsHumansLogistic ModelsProspective StudiesRisk FactorsRisk-TakingSeroepidemiologic StudiesSexual BehaviorSubstance Abuse, IntravenousSyphilisConceptsInjection drug useHHV-8 infectionHepatitis B virusHepatitis C virusHuman immunodeficiency virusHHV-8 seroprevalenceHHV-8Human herpesvirus 8Sexual transmissionRisk factorsHerpesvirus 8Human immunodeficiency virus (HIV) infectionHHV-8 seropositivityHigh-risk sexual behaviorImmunodeficiency virus infectionBlood-borne transmissionDaily injection drug useHispanic ethnic backgroundEnzyme-linked immunosorbentRisk of seropositivityBlood borneSyphilis infectionHIV infectionIndependent predictorsImmunodeficiency virus
1999
Syringe vending machines for injection drug users: an experiment in Marseille, France.
Obadia Y, Feroni I, Perrin V, Vlahov D, Moatti J. Syringe vending machines for injection drug users: an experiment in Marseille, France. American Journal Of Public Health 1999, 89: 1852-4. PMID: 10589315, PMCID: PMC1509009, DOI: 10.2105/ajph.89.12.1852.Peer-Reviewed Original ResearchThe effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research.
Klein R, Flanigan T, Schuman P, Smith D, Vlahov D. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research. The International Journal Of Tuberculosis And Lung Disease 1999, 3: 681-8. PMID: 10460100.Peer-Reviewed Original ResearchConceptsCell countSeronegative womenHigh-risk seronegative womenHuman immunodeficiency virus (HIV) infectionDelayed-type hypersensitivity testingDegree of immunodeficiencyHIV antibody testingImmunodeficiency virus infectionType hypersensitivity responseEffects of immunodeficiencyUrban medical centerDTH antigensDTH testingHIV seropositivesHIV-seronegativesPPD sizeSeropositive womenLymphocyte countHIV infectionAntibody testingHypersensitivity responseTuberculin antigenCutaneous responseHypersensitivity testingTetanus toxoid
1998
Satellite exchange in the Baltimore Needle Exchange Program.
Valente T, Foreman R, Junge B, Vlahov D. Satellite exchange in the Baltimore Needle Exchange Program. Public Health Reports 1998, 113 Suppl 1: 90-6. PMID: 9722814, PMCID: PMC1307731.Peer-Reviewed Original ResearchConceptsPrevention messagesBaltimore Needle Exchange ProgramHIV prevention messagesNeedle exchange programsNeedle exchange program participantsDrug-using networksDrug injectorsNumber of syringesDrug usersDrug useRisk behaviorsLogistic regressionOne-way ANOVAIDUsPrevention materialsProgram effectivenessProgram participantsActivities of SSParticipantsPotential bridgeExchange programsCorrelates of infection control practices in dentistry
Gershon R, Karkashian C, Vlahov D, Grimes M, Spannhake E. Correlates of infection control practices in dentistry. American Journal Of Infection Control 1998, 26: 29-34. PMID: 9503110, DOI: 10.1016/s0196-6553(98)70058-6.Peer-Reviewed Original ResearchPrevalence and Incidence of Hepatitis C Virus Infection Among Young Adult Injection Drug Users
Garfein R, Doherty M, Monterroso E, Thomas D, Nelson K, Vlahov D. Prevalence and Incidence of Hepatitis C Virus Infection Among Young Adult Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: s11-s19. PMID: 9663618, DOI: 10.1097/00042560-199802001-00004.Peer-Reviewed Original ResearchConceptsYoung adult injection drug usersAdult injection drug usersInjection drug usersHepatitis C virus infectionC virus infectionHCV infectionVirus infectionDrug usersHCV-seronegative participantsTransmission of HCVCommunity-based outreachSecond-generation antibodiesHCV seroconversionHCV seroprevalenceCommunity outreach educationProspective studyRisk factorsSemiannual interviewsHigh riskInjecting practicesSterile syringesBivariate analysisLogistic regressionInfectionHCV
1994
Voluntary Testing for Human Immunodeficiency Virus (HIV) in a Prison Population with a High Prevalence of HIV
Behrendt C, Kendig N, Dambita C, Horman J, Lowlor J, Vlahov D. Voluntary Testing for Human Immunodeficiency Virus (HIV) in a Prison Population with a High Prevalence of HIV. American Journal Of Epidemiology 1994, 139: 918-926. PMID: 8166142, DOI: 10.1093/oxfordjournals.aje.a117098.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHIV-seropositive inmatesVoluntary testingHIV seroprevalenceImmunodeficiency virusCurrent syphilis infectionHigh HIV seroprevalenceSimilar risk factorsMandatory HIV testingSyphilis infectionHIV infectionHIV serosurveyHIV testingRisk factorsHigh prevalencePrison entrantsLower riskPrison populationHigh-risk inmatesDrug useSimilar screeningRisk inmatesSeroprevalenceSerosurveyInfection
1993
Differences in Risk Factors for Human Immunodeficiency Virus Type 1 Seroconversion among Male and Female Intravenous Drug Users
Solomon L, Astemborski J, Warren D, Muñoz A, Cohn S, Vlahov D, Nelson K. Differences in Risk Factors for Human Immunodeficiency Virus Type 1 Seroconversion among Male and Female Intravenous Drug Users. American Journal Of Epidemiology 1993, 137: 892-898. PMID: 8484380, DOI: 10.1093/oxfordjournals.aje.a116750.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virus type 1 (HIV-1) seroconversionDrug usersSeronegative controlsRisk factorsFemale intravenous drug usersMale intravenous drug usersSex-specific risk factorsCurrent intravenous drug useHIV-seronegative controlsIntravenous drug useRisk of seroconversionRisk factor dataCase-control studyAge 18 yearsConditional logistic regression techniquesTime of interviewMore sex partnersSeroconversion statusSeroconversion visitHIV seroconversionHIV infectionStudy entrySexual transmissionSeroconversion
1991
HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users.
Royal W, Updike M, Seines O, Proctor T, Nance-Sproson L, Solomon L, Vlahov D, Cornblath D, McArthur J. HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology 1991, 41: 1905-10. PMID: 1745346, DOI: 10.1212/wnl.41.12.1905.Peer-Reviewed Original ResearchConceptsHIV-1 serostatusIntravenous drug usersNeurologic abnormalitiesDrug usersSeronegative intravenous drug usersCD4 cell countHIV-seropositive subjectsHIV-1 infectionNervous system abnormalitiesConstitutional symptomsElectrophysiologic evaluationSeropositive participantsSeropositive subjectsElectrophysiologic abnormalitiesHIV infectionStudy cohortNeurologic diseaseSystem abnormalitiesHomosexual menCell countSerologic groupsCohortAbnormalitiesClear associationNeuropsychological testsUtilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus.
Solomon L, Frank R, Vlahov D, Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. American Journal Of Public Health 1991, 81: 1285-90. PMID: 1928527, PMCID: PMC1405342, DOI: 10.2105/ajph.81.10.1285.Peer-Reviewed Original ResearchConceptsIntravenous drug usersCD4 cell countDrug usersHealth servicesHIV serostatusClinical symptomsHIV-seropositive intravenous drug usersHealth insuranceCell countAsymptomatic HIV-1 infectionSeropositive intravenous drug usersHuman immunodeficiency virus (HIV) infectionHIV-seropositive drug usersOngoing natural history studyLow CD4 countHIV-1 seropositiveImmunodeficiency virus infectionHIV-1 serostatusHealth care utilizationHIV-1 infectionHIV-positive serostatusNatural history studiesHealth care servicesCD4 countMore HIV